Thalidomide combined with irradiation alters the activity of two proteases

  • Authors:
    • Ece Şimşek
    • Esra Aydemir
    • Aylin Fidan Korcum
    • Kayahan Fişkın
  • View Affiliations

  • Published online on: October 31, 2014     https://doi.org/10.3892/mmr.2014.2831
  • Pages: 1535-1541
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the effects of thalidomide, a drug known for its anti‑angiogenic and antitumor properties, at its cytotoxic dose previously determined as 40 µg/ml (according to four cytotoxic test results). The effect of the drug alone and in combination with radiotherapy using Cobalt 60 (60Co) at 45 Gy on the enzymatic activity of substance‑P degrading A disintegrin and metalloproteinase (ADAM)10 and neprilysin (NEP) was investigated in the mouse breast cancer cell lines 4T1 and 4T1 heart metastases post‑capsaicin (4THMpc). Thalidomide (40 µg/ml) exerted differing effects on the activities of ADAM10 and NEP enzymes. In 4T1 cells, 40 µg/ml thalidomide alone did not alter ADAM10 enzyme activity. 60Co irradiation at 45 Gy alone caused a 42% inhibition in ADAM10 activity, however, the inhibition increased to 89% when combined therapy was used. By contrast, in the 4THMpc cell line, 40 µg/ml thalidomide alone induced a 66.6% increase in ADAM10 enzyme activity. Radiotherapy alone and thalidomide with 60Co combined therapy caused a 33.3 and 40% inhibition of ADAM10 activity, respectively. In 4T1 cells, thalidomide alone caused a 40.9% increase in NEP activity. Radiation therapy alone or in combination with the drug caused a 40.7% increase in NEP activity. In more aggressive 4THMpc cells, thalidomide alone caused a 26.6% increase in NEP activity. Radiotherapy alone and combined therapy caused a 33.3 and 37% increase in enzyme activity, respectively. To the best of our knowledge, the present study is the first to demonstrate that thalidomide alone or in combination with radiotherapy exhibits significant cytotoxic effects on 4T1 and 4THMpc mouse breast cancer cell lines indicating that this drug affects the enzymatic activity of ADAM10 and NEP in vitro.
View Figures
View References

Related Articles

Journal Cover

February-2015
Volume 11 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Şimşek E, Aydemir E, Korcum AF and Fişkın K: Thalidomide combined with irradiation alters the activity of two proteases. Mol Med Rep 11: 1535-1541, 2015.
APA
Şimşek, E., Aydemir, E., Korcum, A.F., & Fişkın, K. (2015). Thalidomide combined with irradiation alters the activity of two proteases. Molecular Medicine Reports, 11, 1535-1541. https://doi.org/10.3892/mmr.2014.2831
MLA
Şimşek, E., Aydemir, E., Korcum, A. F., Fişkın, K."Thalidomide combined with irradiation alters the activity of two proteases". Molecular Medicine Reports 11.2 (2015): 1535-1541.
Chicago
Şimşek, E., Aydemir, E., Korcum, A. F., Fişkın, K."Thalidomide combined with irradiation alters the activity of two proteases". Molecular Medicine Reports 11, no. 2 (2015): 1535-1541. https://doi.org/10.3892/mmr.2014.2831